Crossmark

Comparative efficacy of immune checkpoint inhibitor-based regimens versus tyrosine kinase inhibitors in advanced hepatocellular carcinoma stratified by etiology: a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1007/s10147-026-02985-5

Published Online: 2026-02-17

Published Print: 2026-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Peng, Tzu-Rong https://orcid.org/0000-0002-0754-5682
Huang, Yun-Hui

Wu, Ta-Wei

Wu, Chao-Chuan

Hsu, Shuang-Yu

Hsu, Ching-Sheng
License Information

Text and Data Mining valid from 2026-02-17

Version of Record valid from 2026-02-17
More Information

Article History

Received: 7 September 2025

Accepted: 5 February 2026

First Online: 17 February 2026

Declarations

:

: The authors declare no conflicts of interest.

: Not applicable.

: Not applicable.

Document is current

Any future updates will be listed below